157 related articles for article (PubMed ID: 21965303)
41. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.
Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA
Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050
[TBL] [Abstract][Full Text] [Related]
42. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T; Liu L
Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
[TBL] [Abstract][Full Text] [Related]
43. TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndrome.
Katsoulis K; Paschou SA; Hatzi E; Tigas S; Georgiou I; Tsatsoulis A
Hormones (Athens); 2018 Sep; 17(3):359-365. PubMed ID: 29971604
[TBL] [Abstract][Full Text] [Related]
44. Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas.
Columbus J; Chiang Y; Shao W; Zhang N; Wang D; Gaisano HY; Wang Q; Irwin DM; Jin T
J Endocrinol; 2010 Oct; 207(1):77-86. PubMed ID: 20675304
[TBL] [Abstract][Full Text] [Related]
45. Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2.
Howard EW; Been LF; Lerner M; Brackett D; Lightfoot S; Bullen EC; Sanghera DK
BMC Genet; 2013 Apr; 14():28. PubMed ID: 23617586
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the transcriptional machinery bound across the widely presumed type 2 diabetes causal variant, rs7903146, within TCF7L2.
Xia Q; Deliard S; Yuan CX; Johnson ME; Grant SF
Eur J Hum Genet; 2015 Jan; 23(1):103-9. PubMed ID: 24667787
[TBL] [Abstract][Full Text] [Related]
47. Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein level.
Neve B; Le Bacquer O; Caron S; Huyvaert M; Leloire A; Poulain-Godefroy O; Lecoeur C; Pattou F; Staels B; Froguel P
Diabetologia; 2014 Apr; 57(4):785-96. PubMed ID: 24463962
[TBL] [Abstract][Full Text] [Related]
48. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
[TBL] [Abstract][Full Text] [Related]
49.
Justesen L; Ribel-Madsen R; Gillberg L; Hansen NS; Wulff AL; Grunnet LG; Brøns C
Endocr Res; 2019 Aug; 44(3):110-116. PubMed ID: 30721637
[No Abstract] [Full Text] [Related]
50. The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells.
Norton L; Chen X; Fourcaudot M; Acharya NK; DeFronzo RA; Heikkinen S
Nucleic Acids Res; 2014 Dec; 42(22):13646-61. PubMed ID: 25414334
[TBL] [Abstract][Full Text] [Related]
51. Adenosine promotes GATA-2-regulated p53 gene transcription to induce HepG2 cell apoptosis.
Yaguchi T; Nakano T; Gotoh A; Nishizaki T
Cell Physiol Biochem; 2011; 28(4):761-70. PubMed ID: 22178888
[TBL] [Abstract][Full Text] [Related]
52. Transcription factor 7-like 2 controls matrix degradation through nuclear factor κB signaling and is repressed by microRNA-155 in nucleus pulposus cells.
Sun J; Hong J; Sun S; Wang X; Peng Y; Zhou J; Huang Y; Li S; Chen W; Li C; Xu K; Ye W
Biomed Pharmacother; 2018 Dec; 108():646-655. PubMed ID: 30245464
[TBL] [Abstract][Full Text] [Related]
53. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits.
Fritsche L; Sarief M; Wagner R; Stefan N; Lehmann R; Häring HU; Grallert H; Fritsche A; Lechner A
Diabetes Res Clin Pract; 2018 Dec; 146():251-257. PubMed ID: 30419301
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise.
Li Y; Zhang T; Huang Q; Sun Y; Chang X; Zhang H; Zhu Y; Han X
Endocrine; 2016 Nov; 54(2):383-395. PubMed ID: 27160820
[TBL] [Abstract][Full Text] [Related]
55. What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?
Adams JD; Vella A
Metab Syndr Relat Disord; 2018 Oct; 16(8):383-389. PubMed ID: 29993315
[TBL] [Abstract][Full Text] [Related]
56. Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance.
Varghese RT; Viegas I; Barosa C; Marques C; Shah M; Rizza RA; Jones JG; Vella A
Diabetes; 2016 Apr; 65(4):887-92. PubMed ID: 26822092
[TBL] [Abstract][Full Text] [Related]
57. Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans.
Laurenti MC; Dalla Man C; Varghese RT; Andrews JC; Rizza RA; Matveyenko A; De Nicolao G; Cobelli C; Vella A
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32182220
[TBL] [Abstract][Full Text] [Related]
58. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
59. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
60. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women.
Reyes-López R; Pérez-Luque E; Malacara JM
Diabetes Metab Res Rev; 2014 Nov; 30(8):701-6. PubMed ID: 24639413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
